Sana Biotechnology, Inc. - stock earnings
SANA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -88.1 million USD | ? USD |
2023Q3 | 984000 USD | ? USD |
2023Q2 | -114.0 million USD | ? USD |
2023Q1 | -80.2 million USD | ? USD |
2022Q4 | -78.4 million USD | ? USD |
2022Q3 | -83.9 million USD | ? USD |
2022Q2 | -71.8 million USD | ? USD |
2022Q1 | -31.2 million USD | ? USD |
2021Q4 | -110.7 million USD | ? USD |
2021Q3 | -83.3 million USD | ? USD |
2021Q2 | 18.7 million USD | ? USD |
2021Q1 | -180.6 million USD | ? USD |
2020Q4 | -113.2 million USD | 161.5 million USD |
2020Q3 | -51.5 million USD | ? USD |
2020Q2 | -87.8 million USD | ? USD |
2020Q1 | -32.9 million USD | ? USD |
2019Q4 | -43.0 million USD | ? USD |
SANA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -283.3 million USD | ? USD |
2022 | -266.4 million USD | ? USD |
2021 | -344.2 million USD | ? USD |
2020 | -278.6 million USD | ? USD |
2019 | -130.8 million USD | ? USD |
2018 | -26.5 million USD | ? USD |
SANA
Price: $9.63
52 week price:
Earnings Per Share: -1.46 USD
P/E Ratio: -4.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Market Capitalization: 2.0 billion